New

Global ETF Survey Is Live! 600+ ETF Professionals Weigh In. See Results →

Advertisement
Advertisement

CANCvsHRTSETF Comparison

ETF 1
CANC

Tema Oncology ETF

This fund is part of
Tomorrow's Treatments
+0.01%
VS
ETF 2
HRTS

Tema GLP-1, Obesity & Cardiometabolic ETF

This fund is part of
Tomorrow's Treatments
+0.01%

Tema Oncology ETF (CANC) and Tema GLP-1, Obesity & Cardiometabolic ETF (HRTS) belong to the same industry segment: Tomorrow's Treatments. Both CANC and HRTS have the same Total Expense Ratio (TER) of 0.99%. CANC is up 18.27% year-to-date (YTD) with +$67M in YTD flows. HRTS performs worse with 6.07% YTD performance, and -$3M in YTD flows. Run a side-by-side ETF comparison of CANC and HRTS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

CANC vs HRTS performance and flow charts

Performance

-6.0-4.0-2.00.02.04.0%Sep 28Oct 5Oct 12Oct 19Oct 26

Cumulative Flows

01,000,0002,000,0003,000,0004,000,0005,000,000Sep 28Oct 5Oct 12Oct 19Oct 26

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/26/2026
1M3MYTD1Y3Y5Y
Perf.
CANC
HRTS
-1.38%+2.24%
-0.11%+1.93%
+18.27%+6.07%
+33.00%+15.78%
+95.80%n/a
n/an/a
Flows
CANC
HRTS
+$5M-
+$14M-$362K
+$67M-$3M
+$85M-$2M
+$151M-
--
Volatility and drawdown
3M1Y3Y5Y
Volatility
CANC
HRTS
+23.76%+16.49%
+23.19%+16.34%
+22.43%n/a
n/an/a
Max drawdown
CANC
HRTS
-13.09%-8.15%
-13.09%-10.68%
-27.90%n/a
n/an/a
Max drawdown duration
CANC
HRTS
62d68d
62d170d
441dn/a
n/an/a
Trading data

Create an account to view trading data

Join for free
CANC
HRTS
Last sale
10/27/2026 at 1:30 PM
$41.76
$37.61
Previous close
10/26/2026
$40.99
$37.45
Consolidated volume
10/26/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Advertisement
Main metrics
Last update 10/27/2026 at 1:30 PM
Live
Closed
CANC
HRTS
Last price
$41.76
$37.61
1D performance
+1.87%
+0.43%
AuM$209.34 M$55.46 M
E/R0.99%0.99%
Characteristics
CANC
HRTS
Management strategyActiveActive
ProviderTemaTema
Benchmark--
N° of holdings--
Asset class--
Trailing 12m distribution yield
Join
Join
Inception dateAugust 15, 2023November 21, 2023
ESGNoNo
Advertisement
Exposure

Countries

CANC
Data will be available soon
HRTS
Data will be available soon

Sectors

CANC
Data will be available soon
HRTS
Data will be available soon
Advertisement

Diversification

CANC
Data will be available soon
HRTS
Data will be available soon

Top 15 holdings

Data as of January 1, 1970
CANC
Data will be available soon
HRTS
Data will be available soon
Frequently asked questions about CANC and HRTS

How have the CANC and HRTS ETFs performed in 2026?

As of October 26, 2026, CANC is up 18.27% year-to-date (YTD), while HRTS has returned 6.07%. That puts CANC better performer ahead so far this year.

Which ETF is attracting more investor money: CANC or HRTS?

Year-to-date, the CANC ETF saw +$67M in flows, compared to -$3M for HRTS.

Which ETF is more volatile: CANC or HRTS?

Over the past year, CANC had a volatility of 23.19%, while HRTS experienced 16.34%.

Which ETF is bigger: CANC or HRTS?

As of October 26, 2026, CANC holds $209.34 M in assets under management (AUM), while HRTS manages $55.46 M.

Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

Global ETF Survey 2026